Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication.
Welcome to another edition of “3 Things In Biotech,” a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.
The FDA convenes a meeting to discuss Lilly’s rheumatology drug
Company: Eli Lilly (LLY)
Disease: Moderate-to-severe rheumatoid arthritis
News: The FDA is convening a meeting of the Arthritis Advisory Committee to provide insight into the application submitted by LLY for baricitinib in the treatment of rheumatoid arthritis. The original application in this disease was rejected by the agency due to a lack of clinical trial data and safety concerns, which LLY has endeavored to rectify. This meeting will take place on April 23.
Looking forward: This is an odd story, as it was the ascension of a new FDA commissioner that prompted the re-application, without any new data acquired. LLY is firm in its belief that the safety data are not particularly alarming. So it’s going to be somewhat telling to see what the ultimate outcome is, as it could signal a different direction for the FDA that many analysts have been anticipating in the Trump era.
Top Biotech Stocks To Watch For 2019: Gogo Inc.(GOGO)
- [By Daniel Sparks]
Shares of satellite communications company Iridium Communications(NASDAQ:IRDM) jumped as much as 16.4% on Friday,following the announcement of a partnership between Iridium and in-flight broadband connectivity and wireless entertainment services company Gogo(NASDAQ:GOGO). At the time of this writing, Iridium stock is up 11.3% on Friday.
- [By Nicholas Rossolillo]
Another newsworthy item the last couple of weeks was that in-flight broadband internet provider Gogo (NASDAQ:GOGO) will begin making devices supporting Iridium Certus, the broadband internet service enabled by the NEXT satellite constellation. Testing in aircraft will begin later this year, and commercial rollout is expected in mid-2019.
- [By Stephan Byrd]
Gogo Inflight Internet (NASDAQ:GOGO) was the recipient of a large increase in short interest in May. As of May 15th, there was short interest totalling 36,604,500 shares, an increase of 11.5% from the April 30th total of 32,815,192 shares. Currently, 65.4% of the company’s shares are sold short. Based on an average trading volume of 3,480,011 shares, the short-interest ratio is currently 10.5 days.
- [By Anders Bylund]
Shares of Gogo (NASDAQ:GOGO) closed 13.1% lower on Friday, having traded as much as 14% lower earlier in the day. The provider of in-flight broadband connectivity services reported strong first-quarter results with a mixed bag of full-year guidance, and investors decided to focus on the weak spots in that varied quilt of company news.
Top Biotech Stocks To Watch For 2019: NVR Inc.(NVR)
- [By Jason Hall]
Priestley:Yeah,absolutely. The first stock that you mentioned was NVR (NYSE:NVR). They focus on building luxury homes in Delaware, Maryland, North Carolina, Pennsylvania,and Virginia. They have three distinct brands:Ryan Homes, NV Homes and Heartland Homes. They’reactually the most expensive, I think, of the stocks that we’re going to talk about today. Their P/E is at 24X. But they’re also the biggest, and the past 12 months have seen the stock come up almost 50%. So, great pick! What exactly attracted you to NVR?
- [By JJ Kinahan]
Next week is big for housing numbers. March existing home sales figures are scheduled for Monday and new home sales for March along with the February S&P Case-Shiller Home Price Index on Tuesday. As for homebuilders, Pulte Group, Inc. (NYSE: PHM) is scheduled to report Q1 results Tuesday, and D.R. Horton Inc (NYSE: DHI) is scheduled to report fiscal Q2 numbers on Thursday. The industry already has seen strong Q1 results from Lennar Corporation (NYSE: LEN), and housing starts and building permits in March rose more than expected. These results, as well as those and the economic data from next week could provide clues for the industry going forward. After NVR, Inc. (NYSE: NVR) reports results this morning, Meritage Homes Corp. (NYSE: MTH) releases its Q1 results April 25. We’ll have to wait until next month for some of the other homebuilders, as well as from home improvement companies Home Depot, Inc. (NYSE: HD) and Lowe’s Companies Inc (NYSE: LOW), before we get a more complete snapshot of the housing market.
- [By Tyler Crowe]
This isn’t to say that investing in homebuilding is an awful idea — the trends mentioned above are incredibly strong indicators that investing in housing can pay off. What matters is you have to be incredibly discerning when selecting the business in which you want to invest. To me, there are only two stocks that are really worth exploring as potential investments:LGI Homes (NASDAQ:LGIH) and NVR Inc. (NYSE:NVR). Here’s why these two homebuilders stand out among the crowd.
- [By Stephan Byrd]
NVR, Inc. (NYSE:NVR) Director Susan Williamson Ross purchased 70 shares of the company’s stock in a transaction on Tuesday, May 15th. The stock was purchased at an average price of $2,995.20 per share, for a total transaction of $209,664.00. Following the purchase, the director now directly owns 64,191 shares of the company’s stock, valued at approximately $192,264,883.20. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Top Biotech Stocks To Watch For 2019: Federal Signal Corporation(FSS)
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Federal Signal (FSS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Prudential Financial Inc. grew its holdings in shares of Federal Signal Co. (NYSE:FSS) by 63.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 234,061 shares of the conglomerate’s stock after purchasing an additional 90,560 shares during the period. Prudential Financial Inc.’s holdings in Federal Signal were worth $5,154,000 as of its most recent SEC filing.
- [By Logan Wallace]
OppenheimerFunds Inc. lowered its holdings in shares of Federal Signal Co. (NYSE:FSS) by 14.6% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 33,592 shares of the conglomerate’s stock after selling 5,741 shares during the period. OppenheimerFunds Inc.’s holdings in Federal Signal were worth $739,000 as of its most recent SEC filing.